OBJECTIVES: Stigma associated with mental illness is an important yet understudied issue among Latinos. This study examined the psychometric properties of four stigma measures with a sample of Spanish-speaking Latino primary care patients. The study evaluated the scale for Perceived Discrimination Devaluation (PDD), the Stigma Concerns About Mental Health Care (SCMHC) scale, the Latino Scale for Antidepressant Stigma (LSAS), and the Social Distance (SD) scale. METHODS: Participants (N=200) were low-income Latinos who were screened for depression with the Patient Health Questionnaire (PHQ-2) and asked about their depression treatment history, and they completed the four stigma measures at two time points (25 and 30 months from baseline). The four stigma measures were examined for internal consistency, convergent validity, construct validity, and criterion-related validity. RESULTS: The factor-analytic results generally provided support for the construct validity of the measures. The four stigma measures also demonstrated internal consistency between two time points. Patients who reported greater social distance from individuals with depression were more likely to have been receiving treatment for emotional care in the past three months (odds ratio [OR]=.70, p<.05). Also, Latinos who scored high on the SCMHC (OR=.64, p<.05) and LSAS (OR=.77, p<.05) were less likely to have been taking antidepressant medications. CONCLUSIONS: The SCMHC, LSAS, and SD scales received support for their reliability and construct validity. Results also showed some support for their criterion-related validity. A more mixed picture emerged for the PDD. Stigma ratings were associated with depression treatment utilization. Stigma ratings changed over time and were associated with treatment experiences.
OBJECTIVES: Stigma associated with mental illness is an important yet understudied issue among Latinos. This study examined the psychometric properties of four stigma measures with a sample of Spanish-speaking Latino primary care patients. The study evaluated the scale for Perceived Discrimination Devaluation (PDD), the Stigma Concerns About Mental Health Care (SCMHC) scale, the Latino Scale for Antidepressant Stigma (LSAS), and the Social Distance (SD) scale. METHODS:Participants (N=200) were low-income Latinos who were screened for depression with the Patient Health Questionnaire (PHQ-2) and asked about their depression treatment history, and they completed the four stigma measures at two time points (25 and 30 months from baseline). The four stigma measures were examined for internal consistency, convergent validity, construct validity, and criterion-related validity. RESULTS: The factor-analytic results generally provided support for the construct validity of the measures. The four stigma measures also demonstrated internal consistency between two time points. Patients who reported greater social distance from individuals with depression were more likely to have been receiving treatment for emotional care in the past three months (odds ratio [OR]=.70, p<.05). Also, Latinos who scored high on the SCMHC (OR=.64, p<.05) and LSAS (OR=.77, p<.05) were less likely to have been taking antidepressant medications. CONCLUSIONS: The SCMHC, LSAS, and SD scales received support for their reliability and construct validity. Results also showed some support for their criterion-related validity. A more mixed picture emerged for the PDD. Stigma ratings were associated with depression treatment utilization. Stigma ratings changed over time and were associated with treatment experiences.
Authors: Alejandro Interian; Igda E Martinez; Peter J Guarnaccia; William A Vega; Javier I Escobar Journal: Psychiatr Serv Date: 2007-12 Impact factor: 3.084
Authors: Jodi M Gonzalez; Deborah A Perlick; David J Miklowitz; Richard Kaczynski; Melissa Hernandez; Robert A Rosenheck; Jenifer L Culver; Michael J Ostacher; Charles L Bowden Journal: Psychiatr Serv Date: 2007-01 Impact factor: 3.084
Authors: William Armando Vega; Marvin Karno; Margerita Alegria; Jennifer Alvidrez; Guillermo Bernal; Michael Escamilla; Javier Escobar; Peter Guarnaccia; Janis Jenkins; Alex Kopelowicz; Isabel T Lagomasino; Roberto Lewis-Fernandez; Humberto Marin; Steven Lopez; Sana Loue Journal: Psychiatr Serv Date: 2007-03 Impact factor: 3.084
Authors: Mohsen Bazargan; Chizobam O Ani; David W Hindman; Shahrzad Bazargan-Hejazi; Richard S Baker; Douglas Bell; Michael Rodriquez Journal: J Altern Complement Med Date: 2008-06 Impact factor: 2.579
Authors: Leopoldo J Cabassa; Hans Oh; Jennifer L Humensky; Jennifer B Unger; Gregory B Molina; Melvin Baron Journal: Psychiatr Serv Date: 2014-12-01 Impact factor: 3.084
Authors: Christina L Rush; Margaret Darling; Maria Gloria Elliott; Ivis Febus-Sampayo; Charlene Kuo; Juliana Muñoz; Ysabel Duron; Migdalia Torres; Claudia Campos Galván; Florencia Gonzalez; Larisa Caicedo; Anna Nápoles; Roxanne E Jensen; Emily Anderson; Kristi D Graves Journal: Qual Life Res Date: 2014-11-08 Impact factor: 4.147
Authors: Melinda M Davis; Margaret Spurlock; Kristen Dulacki; Thomas Meath; Hsin-Fang Grace Li; Dennis McCarty; Donald Warne; Bill Wright; K John McConnell Journal: J Rural Health Date: 2015-10-30 Impact factor: 4.333
Authors: Erik Fernandez Y Garcia; Peter Franks; Anthony Jerant; Robert A Bell; Richard L Kravitz Journal: J Am Board Fam Med Date: 2011 Jan-Feb Impact factor: 2.657